Delivery Order SPE2DB22D3301-SPE2DB25FX4NK
Award Date
10/28/24
Potential Completion Date
11/19/24
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024, with a ceiling value of $5,779.12 and a completion date of December 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,586.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 120 MG vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,275.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the pharmaceutical product BENLYSTA 400 MG VIALS, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $10,076.00 and a completion date of July 10, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has a significant...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,379.09 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,793.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 29, 2024, with an ultimate completion date of September 20, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,777.72 firm fixed-price delivery order is for BENLYSTA 400 MG VIALS, with a completion date of June 6, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the provision of BENLYSTA 400 MG vials. The contract has a ceiling value of $5,038.00 and a completion date of June 25, 2024. This award is issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 400 MG VIALS, with a ceiling value of $5,259.24 and a completion date of April 28, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency, a defense agency. The $4,987.78 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 21, 2025, with a completion date of June 12, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...